Interaction between apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and mild cognitive impairment

被引:0
|
作者
Mauri, Marco
Sinforiani, Elena
Bono, Giorgio
Cittadella, Rita
Quattrone, Aldo
Boller, Francois
Nappi, Giuseppe
机构
[1] Univ Insubria, Dept clin Med, Sect Neurol, Varese, Italy
[2] IRCSS, C Mondino Inst Neurol Fdn, Pavia, Italy
[3] CNR, Inst Neurol Sci, Cosenza, Italy
[4] Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med Sci, Catanzaro, Italy
[5] INSERM, U549, F-75005 Paris, France
[6] Univ Roma La Sapienza, Dept Neurol & Otorhinolaringol, I-00161 Rome, Italy
关键词
Alzheimer's disease; apolipoproteins; mild cognitive impairment; traumatic brain injury;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several pathogenetic factors seem to contribute to the development of Alzheimer's disease (AD). Some data point to a role for traumatic brain injury (TBI), but this suggestion is not universally supported. Mayeux et al. have shown that TBI increases the risk of AD, but only through a synergistic relationship with apolipoprotein epsilon (Apo E) 4. We present the results of a cross-sectional and longitudinal study of the relationship between these factors, conducted in northern and southern Italy. We studied 337 consecutive patients with probable AD and 63 subjects with mild cognitive impairment (MCI). Information concerning head injuries was collected by interview of informants and review of medical records. Twenty-one patients with AD and 9 with MCI were found to have a history of TBI with loss of consciousness. AD and MCI patients with a history of TBI, compared with control groups matched for age, sex, education and degree of mental impairment, showed more marked depressive and behavioural disturbances (Global Deterioration Scale and Neuropsychiatric Inventory, p<0.05). Six- and 12-month follow up of both groups did not show significant differences in the rate of progression of cognitive changes. A high frequency of Apo E 4 was detected in the patients with TBI and cognitive impairment (40.5% in the AD and 11% in the MCI subgroups). The distribution of the epsilon 4 allele in our control group was 4%, comparable to that found in the Italian population. Distribution of the above parameters was similar in patients from northern and southern Italy. The higher frequency of TBI and Apo E 4 genotype among AD and MCI patients confirms the synergistic interaction of environmental and genetic factors in the development of dementia. Our data do not suggest that the presence of these two factors influences the clinical presentation or the course of the disease.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 50 条
  • [31] Relationships between optic nerve damage and the severity of cognitive impairment in patients with mild cognitive impairment and Alzheimer's disease
    Zhang, Lina
    Xu, Yuming
    Zhu, Yu
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (13): : 5708 - 5712
  • [32] COGNITIVE RESERVE AND THE INTERACTION BETWEEN PREMORBID IQ AND MILD TRAUMATIC BRAIN INJURY
    Stenberg, Jonas
    Haberg, Asta K.
    Olsen, Alexander
    Follestad, Turid
    Iverson, Grant L.
    Berg, Simen Saksvik
    Karlsen, Rune Hatlestad
    Vik, Anne
    Skandsen, Toril
    JOURNAL OF NEUROTRAUMA, 2018, 35 (16) : A107 - A107
  • [33] The Relationship Between Sleep Disturbance and Apolipoprotein E ε4 in Adults With Mild Cognitive Impairment and Alzheimer's Disease Dementia: An Integrative Review
    Wei, Wanrui
    Wang, Kairong
    Shi, Jiyuan
    Li, Zheng
    BIOLOGICAL RESEARCH FOR NURSING, 2022, 24 (03) : 327 - 337
  • [34] Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease
    Guidi, I
    Galimberti, D
    Lonati, S
    Novembrino, C
    Bamonti, F
    Tiriticco, M
    Fenoglio, C
    Venturelli, E
    Baron, P
    Bresolin, N
    Scarpini, E
    NEUROBIOLOGY OF AGING, 2006, 27 (02) : 262 - 269
  • [35] Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
    Kesler, Anat
    Vakhapova, Veronika
    Korczyn, Amos D.
    Naftaliev, Elvira
    Neudorfer, Meira
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (07) : 523 - 526
  • [36] Biomarkers of Alzheimer's disease in the CSF of patients with mild cognitive impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Rodriguez-Borja, E.
    Ruiz-Vegara, M.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    JOURNAL OF NEUROLOGY, 2010, 257 : S166 - S166
  • [37] Inflammation in mild cognitive impairment and mild Alzheimer's disease
    Santana, I
    Guerreiro, R
    Paiva, A
    Sarmento, A
    Santiago, B
    Barbosa, V
    Oliveira, C
    NEUROBIOLOGY OF AGING, 2004, 25 : S534 - S534
  • [38] Diverse proteins aggregate in mild cognitive impairment and Alzheimer's disease brain
    Kepchia, Devin
    Huang, Ling
    Dargusch, Richard
    Rissman, Robert A.
    Shokhirev, Maxim N.
    Fischer, Wolfgang
    Schubert, David
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [39] Molecular imaging of brain amyloid in mild cognitive impairment and Alzheimer's disease
    Paul M Matthews
    Nature Clinical Practice Neurology, 2007, 3 : 366 - 367
  • [40] Molecular imaging of brain amyloid in mild cognitive impairment and Alzheimer's disease
    Matthews, P. M.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (07): : 366 - 367